RE:RE:RE:Question?Eoganacht wrote: The segment was very postive, but there was no mention of the exploratory endpoint of efficacy in phase 1. I wish Dr. Jewett had included a sentence stating something like: 'the phase 1 trial, as well as demonstrating safety, gave clear and encouraging signs of efficacy which the phase 2 trial is designed (or expected) to corroborate'
I'm sure there was a reason for presenting it the way they did but that reason is not clear to me.
langosta wrote: Dontworry1 wrote: I am surprised at the underwhelming response from this board to the Bnn interview. I thought it was cool, so why the lack of discussion about it? Phase 2 on the way, a pp to get us going, prove phase 2 we are golden? No?
I just wish that Dr. Jewitt had not used that word 'assuming' so many times. We should be trying to raise interest and enthusiasm in watchers. That word tends to raise doubt in the process. imo.
I guess Dr. Jewett (spelled his name right this time) has to be particularly careful in his wording and not promise the moon (or nasdaq by 2016) as someone in the organization forecast. We have to leave that type of hype to the 'hole in the ground' blue sky miners. :-)